SUMMARY Forty-nine Israeli Jewish patients with rheumatoid arthritis (RA) were studied for their HLA A, B, C, DR antigen frequency. A significant increase in HLA Aw3l and HLA DR1 was observed (p<5 100' and p<5 10 ' respectively). 45% of Aw31 positive patients were seronegative for rheumatoid factor, while most HLA DR1 positive individuals were seropositive. DR5 was found to be significantly decreased (p<5 10-4). Contrary to previous reports, DRw4 was found to be within the range of antigen frequency of the controls (34*7 % vs. 32 %). It is suggested that in our population of patients Aw3l and DR1 and not DR4 are highly associated with adult onset of RA.
Rheumatoid arthritis (RA) is a diseases with abundant evidence for immunological abnormalities, and it was therefore of interest to look for its associations with the major histocompatibility complex.' In the past, testing for the HLA A and B polymorphisms did not yield any significant associations with RA,' but, when HLA D and DR were described and tested for, it was readily established that adult onset of RA is significantly associated with HLA Dw4 and DR4.3-6 These observations were later confirmed by several investigators working collaboratively during the 7th and 8th International Histocompatibility Workshops.7 8 In familial RA it was later possible to map the susceptibility locus RLA-1 to chromosome 6, centromeric to locus HLA D.9
We have observed in the past that our population does not always follow the same HLA and disease association,'01' and it seemed important to reevaluate the situation in our RA patients. Table. HLA Aw3l and DR1 were both increased. Aw3l frequency was 18 4 % in the total patient group compared with less than 1 % in the control population (p<5 10-'). Similar results were obtained when the (Table 2 ). Aw31 and Bw35 were each negatively associated with the presence of the rheumatoid factor (p<5 -10' and p<4'103 respectively). DRw4 was highly associated with prolonged morning stiffness (p<24102) and DR5 was associated with severe symptoms at onset but favourable response to therapy (p<4-102 and p<2.102).
Discussion
It has been suggested in the past that rheumatoid arthritis may have more than one aetiology, and our results tend to support this contention. In our population of RA patients the pattern of HLA association is different from what has been described before. '' HLA Aw31 and DR1, and not DR4, are significantly associated with RA. The excess of Aw31 among our patients has no matched antigen in the other populations. Increased frequency of DR1 and Aw31 was not due to linkage disequillibrium between these antigens, since they were found independently increased (2 x 2 tables for association between DR1 and Aw3 1 resulted in a x2 of 3-0; p=7-5 x 10-2). 45% of Aw31 positive RA patients were seronegative, while most DR1 positive individuals were seropositive. It is possible, therefore, that in our population of RA patients 2 subtypes of disease exist: (a) seronegative Aw3l positive; and (b) seropositive DR1 positive. The reduced frequency of DR5 was described also among non-Israeli Jewish patients.' It is noteworthy that this antigen was associated with severe manifestations at onset but with a favourable response to therapy. It seems therefore that the presence of this antigen is related to resistance to the development of the disease and to a better prognosis in those who contracted it.
DR4, when present, was associated with severe clinical symptoms such as prolonged morning stiffness.
In conclusion, our RA patients exhibit a different pattern of HLA association. We could delineate 2 distinct subtypes, Aw3l seronegative and DR1 seropositive. Both subtypes, however, did not vary with respect to the severity of their clinical symptoms or response to therapy. It is possible that the lack of clinical discrimination between these 2 subtypes resulted from the rigorous criteria employed in patient selection in order to eliminate questionable cases. 
